Justin Arnall, PharmD, BCOP, Breanna Taylor, PharmD, BCOP, and Jeff Goff, RPh, MS, discuss how expanding IV iron indications across cardiology, oncology, and CKD are reshaping the pharmacist's role in formulary strategy, product stewardship, and patient identification.
Justin Arnall, Breanna Taylor, and Jeff Goff examine how step therapy, prior authorizations, and logistical hurdles delay IV iron treatment, and where pharmacists can intervene to secure overrides and streamline access for patients.
Justin Arnall, Breanna Taylor, and Jeff Goff break down how dosing schedules, infusion chair time, and preparation complexity factor into product selection and infusion center capacity, and how pharmacists can help institutions deliver IV iron more efficiently.
Justin Arnall, Breanna Taylor, and Jeff Goff weigh in on hypophosphatemia risk across IV iron formulations, strategies for managing infusion reactions, and whether generic versus branded products affect reaction rates in practice.
